Comparative Effects of Moxonidine and Bisoprolol on Bone Metabolism, Vascular and Cellular Markers of Aging, Blood Pressure in Hypertensive Postmenopausal Women (COMPASS)
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 01 Dec 2017
At a glance
- Drugs Moxonidine (Primary) ; Bisoprolol
- Indications Hypertension; Metabolic bone diseases
- Focus Biomarker; Pharmacodynamics
- Acronyms COMPASS
- 28 Nov 2017 Planned End Date changed from 1 Oct 2017 to 1 Dec 2017.
- 28 Nov 2017 Planned primary completion date changed from 1 Sep 2017 to 1 Dec 2017.
- 28 Nov 2017 Status changed from recruiting to active, no longer recruiting.